Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719019 | SCV000725687 | likely benign | not provided | 2019-01-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000707338 | SCV000836430 | likely benign | Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3 gain of function | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000768099 | SCV000899001 | uncertain significance | Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3-related early-onset multisystem autoimmune disease | 2021-03-30 | criteria provided, single submitter | clinical testing | STAT3 NM_139276.2 exon 23 p.Gly743Val (c.2228G>T): This variant has not been reported in the literature but is present in 34/126596 European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs151033214). This variant is present in ClinVar (Variation ID:514074). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV001719019 | SCV004698799 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | STAT3: PP2, BS2 |
Mayo Clinic Laboratories, |
RCV001719019 | SCV005412715 | uncertain significance | not provided | 2024-05-30 | criteria provided, single submitter | clinical testing | PP2, PS3_supporting |
Center for Genomic Medicine, |
RCV005231171 | SCV005872167 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003935696 | SCV004765643 | uncertain significance | STAT3-related disorder | 2024-01-12 | no assertion criteria provided | clinical testing | The STAT3 c.2228G>T variant is predicted to result in the amino acid substitution p.Gly743Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.026% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |